• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科恶性肿瘤化疗患者使用低剖面皮下植入式静脉通路装置的机械故障发生率。

Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.

机构信息

Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.

出版信息

Gynecol Oncol. 2011 Oct;123(1):54-7. doi: 10.1016/j.ygyno.2011.06.012. Epub 2011 Jul 13.

DOI:10.1016/j.ygyno.2011.06.012
PMID:21742372
Abstract

OBJECTIVE

The purpose of this study was to investigate the incidence of mechanical complications associated with low-profile subcutaneous implantable venous access devices in gynecologic oncology patients.

METHODS

Gynecologic oncology patients with low-profile Port-a-Caths implanted between March 2005 and July 2006 were identified into a computerized database. Patient demographics, operative complications, number of chemotherapy cycles, duration of implantation, and mechanical complications were collected. Primary outcomes included port leakage, catheter fracture, and catheter embolization.

RESULTS

112 patients underwent 115 Port-a-Cath placements with low profile single-lumen plastic ports with Groshong-valved catheters. Mean Port-a-Cath indwelling duration was 197 days (range: 4-395) with a mean number of 12 chemotherapy cycles (range 0-64). The cumulative complication rate necessitating removal or replacement was 15%. Of the 14 Port-a-Caths removed, ten (8.7%) were secondary to mechanical malfunction: one for leakage at the port site, two for catheter fracture, and seven for fracture with catheter embolization to the heart or pulmonary vasculature-most commonly the right ventricle. Patients with embolization were asymptomatic and all embolized catheters were successfully retrieved by interventional radiology without complications.

CONCLUSIONS

The rates of catheter fracture and embolization have previously been reported to be low in patients with subcutaneous Port-a-Caths, and have not been studied in patients receiving low-profile subcutaneous Port-a-Caths. This study suggests that catheter fracture may be more common (8.7%) and must be considered in patients with malfunctioning low-profile Port-a-Caths. Embolized catheters can be removed by interventional radiology without significant adverse affects.

摘要

目的

本研究旨在探讨妇科肿瘤患者中使用低轮廓皮下植入式静脉通路装置相关机械并发症的发生率。

方法

我们将 2005 年 3 月至 2006 年 7 月间接受低轮廓 Port-a-Cath 植入的妇科肿瘤患者纳入计算机数据库。收集患者的人口统计学数据、手术并发症、化疗周期数、植入时间和机械并发症等资料。主要结局包括端口渗漏、导管断裂和导管栓塞。

结果

共有 112 例患者接受了 115 例低轮廓单腔塑料端口与 Groshong 瓣膜导管的 Port-a-Cath 植入术。Port-a-Cath 平均留置时间为 197 天(范围:4-395),平均化疗周期数为 12 个(范围 0-64)。需要移除或更换的总并发症发生率为 15%。在 14 个被移除的 Port-a-Cath 中,有 10 个(8.7%)是由于机械故障所致:1 个是由于端口处渗漏,2 个是由于导管断裂,7 个是由于导管断裂并栓塞至心脏或肺血管-最常见的是右心室。栓塞的患者无症状,所有栓塞的导管均通过介入放射学成功取出,无并发症。

结论

以前已经报道过皮下 Port-a-Cath 患者中导管断裂和栓塞的发生率较低,而在接受低轮廓皮下 Port-a-Cath 的患者中尚未进行研究。本研究表明,导管断裂的发生率可能更高(8.7%),在低轮廓 Port-a-Cath 功能障碍的患者中应考虑这一问题。栓塞的导管可通过介入放射学取出,无明显不良影响。

相似文献

1
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.妇科恶性肿瘤化疗患者使用低剖面皮下植入式静脉通路装置的机械故障发生率。
Gynecol Oncol. 2011 Oct;123(1):54-7. doi: 10.1016/j.ygyno.2011.06.012. Epub 2011 Jul 13.
2
Complications associated with an implantable vascular access device.与植入式血管通路装置相关的并发症。
J Pediatr Surg. 2006 Sep;41(9):1582-7. doi: 10.1016/j.jpedsurg.2006.05.022.
3
A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.实体瘤化疗患者中 Hickman 导管和植入式静脉输液港相关并发症的比较
Clin Oncol (R Coll Radiol). 2007 Sep;19(7):551-6. doi: 10.1016/j.clon.2007.04.003. Epub 2007 May 22.
4
Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.用于妇科肿瘤患者中心静脉通路的外置式Groshong导管和Hickman端口。
Gynecol Oncol. 1993 Dec;51(3):372-6. doi: 10.1006/gyno.1993.1306.
5
Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.预测皮下植入式中心静脉导管功能的因素:妇科恶性肿瘤患者导管尖端位置与导管功能障碍之间的关系
Gynecol Oncol. 2001 Dec;83(3):533-6. doi: 10.1006/gyno.2001.6433.
6
Radiologic placement of a low profile implantable venous access port in a pediatric population.小儿人群中低调可植入式静脉通路端口的放射学放置
Cardiovasc Intervent Radiol. 2001 Nov-Dec;24(6):395-9. doi: 10.1007/s00270-001-0071-1. Epub 2001 Nov 8.
7
Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.完全植入式导管系统在妇科肿瘤患者中的长期应用经验。
J Am Coll Surg. 1994 Feb;178(2):164-6.
8
Peripheral infusion ports for central venous access in patients with gynecologic malignancies.用于妇科恶性肿瘤患者中心静脉通路的外周输液港
Gynecol Oncol. 1996 Mar;60(3):397-9. doi: 10.1006/gyno.1996.0061.
9
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.用于实体瘤化疗的、连接到Groshong导管的长期完全植入式中心静脉通路端口:178例使用单一类型装置的经验
Eur J Cancer. 1997 Jul;33(8):1190-4. doi: 10.1016/s0959-8049(97)00039-7.
10
The mechanisms of failure of totally implantable central venous access system: analysis of 73 cases with fracture of catheter.完全植入式中心静脉通路系统故障的机制:73 例导管断裂分析。
Eur J Surg Oncol. 2010 Jan;36(1):100-3. doi: 10.1016/j.ejso.2009.07.011. Epub 2009 Aug 25.

引用本文的文献

1
Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer.经外周静脉穿刺中心静脉置管与肿瘤植入式静脉输液港在甲状腺癌患者化疗中的比较
Oncol Lett. 2020 Aug;20(2):1657-1662. doi: 10.3892/ol.2020.11732. Epub 2020 Jun 15.
2
Long-term outcomes of totally implantable venous access devices.完全植入式静脉通路装置的长期预后
Support Care Cancer. 2017 Jul;25(7):2049-2054. doi: 10.1007/s00520-017-3592-0. Epub 2017 Feb 9.